- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Clinical-grade ADCs, aliquoted from commercial EU-Licensed medicines
Showing 1–12 of 13 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
BCMA |
Antibody-drug conjugate (ADC) |
Blenrep® |
50 mg/mL |
– |
2 mg |
tba |
tba |
649,00 € |
||
CD30 |
Antibody-drug conjugate (ADC) |
Adcetris® |
5 mg/mL |
– |
2 mg |
-80°C |
02/2025 |
785,00 € |
||
CD30 |
Antibody-drug conjugate (ADC) |
Adcetris® |
5 mg/mL |
– |
5 mg |
-80°C |
04/2026 |
1.277,00 € |
||
Nectin-4 |
Antibody-drug conjugate (ADC) |
Padcev® |
10 mg/mL |
– |
1 mg |
-80 °C |
12/2023 |
355,00 € |
||
Nectin-4 |
Antibody-drug conjugate (ADC) |
Padcev® |
10 mg/mL |
– |
1 mg |
-80 °C |
08/2024 |
355,00 € |
||
CD33 |
Antibody-drug conjugate (ADC) |
Mylotarg® |
1 mg/mL |
– |
0,1 mg |
-80°C |
08/2024 |
1.127,00 € |
||
CD33 |
Antibody-drug conjugate (ADC) |
Mylotarg® |
1 mg/mL |
– |
0,1 mg |
-80°C |
03/2025 |
1.127,00 € |
||
CD22 |
Antibody-drug conjugate (ADC) |
Besponsa® |
0,25 mg/mL |
– |
0,02 mg |
tba |
tba |
1.502,00 € |
||
CD19 |
Antibody-drug conjugate (ADC) |
Zynlonta® |
5 mg/mL |
– |
0,2 mg |
tba |
tba |
2.967,00 € |
||
CD79b |
Antibody-drug conjugate (ADC) |
Polivy® |
20 mg/mL |
– |
1 mg |
-80 °C |
06/2024 |
536,00 € |
||
Trop-2-directed ADC |
Antibody-drug conjugate (ADC) |
Trodelvy® |
10 mg/mL |
– |
4 mg |
-80°C |
08/2025 |
299,00 € |
||
HER2 |
Antibody-drug conjugate (ADC) |
Enhertu® |
20 mg/mL |
– |
2 mg |
-80°C |
08/2026 |
482,00 € |
||
HER2 |
Antibody-drug conjugate (ADC) |
Kadcyla® |
20 mg/mL |
– |
2 mg |
-80°C |
07/2023 |
348,30 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin